

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.27195539 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.22274107 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.86919606 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.56807572 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.46589815 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.46589815 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.46589815 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.46589815 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 5.46589815 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.46589815 |
| 11 | vocalization behavior (GO:0071625) | 5.44226430 |
| 12 | synaptic vesicle exocytosis (GO:0016079) | 5.29165517 |
| 13 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.25102276 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.25010374 |
| 15 | negative regulation of cell killing (GO:0031342) | 5.25010374 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.23554083 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.16159033 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.15326003 |
| 19 | glutamate secretion (GO:0014047) | 5.11633440 |
| 20 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.01688392 |
| 21 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.97063445 |
| 22 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.78018364 |
| 23 | response to peptidoglycan (GO:0032494) | 4.76476842 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.70629448 |
| 25 | neuron cell-cell adhesion (GO:0007158) | 4.69421702 |
| 26 | neutrophil activation involved in immune response (GO:0002283) | 4.67462563 |
| 27 | neurotransmitter secretion (GO:0007269) | 4.65455194 |
| 28 | exploration behavior (GO:0035640) | 4.52390949 |
| 29 | proline transport (GO:0015824) | 4.49515755 |
| 30 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.47450790 |
| 31 | detection of other organism (GO:0098543) | 4.45985609 |
| 32 | sodium ion export (GO:0071436) | 4.45723428 |
| 33 | regulation of synaptic vesicle transport (GO:1902803) | 4.45578471 |
| 34 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.41971583 |
| 35 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.41693778 |
| 36 | protein localization to synapse (GO:0035418) | 4.36544239 |
| 37 | detection of bacterium (GO:0016045) | 4.33621958 |
| 38 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.30741399 |
| 39 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.25024691 |
| 40 | gamma-aminobutyric acid transport (GO:0015812) | 4.23087714 |
| 41 | dendritic spine morphogenesis (GO:0060997) | 4.21819399 |
| 42 | cellular potassium ion homeostasis (GO:0030007) | 4.21257393 |
| 43 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.18286953 |
| 44 | macrophage activation involved in immune response (GO:0002281) | 4.18150049 |
| 45 | leukocyte aggregation (GO:0070486) | 4.16332091 |
| 46 | regulation of synapse structural plasticity (GO:0051823) | 4.13036914 |
| 47 | neuronal action potential propagation (GO:0019227) | 4.07822194 |
| 48 | * layer formation in cerebral cortex (GO:0021819) | 4.04316845 |
| 49 | glutamate receptor signaling pathway (GO:0007215) | 3.94138240 |
| 50 | neuromuscular process controlling posture (GO:0050884) | 3.92867549 |
| 51 | detection of external biotic stimulus (GO:0098581) | 3.91931945 |
| 52 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.83814065 |
| 53 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.83333396 |
| 54 | neurotransmitter transport (GO:0006836) | 3.82899946 |
| 55 | detection of molecule of bacterial origin (GO:0032490) | 3.80943299 |
| 56 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.80647963 |
| 57 | activation of protein kinase A activity (GO:0034199) | 3.80380624 |
| 58 | response to host immune response (GO:0052572) | 3.77033193 |
| 59 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.77033193 |
| 60 | response to host (GO:0075136) | 3.76136804 |
| 61 | response to host defenses (GO:0052200) | 3.76136804 |
| 62 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.76136804 |
| 63 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.74888166 |
| 64 | synaptic transmission, glutamatergic (GO:0035249) | 3.71503457 |
| 65 | regulation of leukocyte degranulation (GO:0043300) | 3.68402064 |
| 66 | regulation of mast cell degranulation (GO:0043304) | 3.65616029 |
| 67 | long-term memory (GO:0007616) | 3.64215850 |
| 68 | neutrophil activation (GO:0042119) | 3.64073171 |
| 69 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.63270357 |
| 70 | regulation of neurotransmitter levels (GO:0001505) | 3.62184920 |
| 71 | neuromuscular process controlling balance (GO:0050885) | 3.60552939 |
| 72 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.59605854 |
| 73 | neuron recognition (GO:0008038) | 3.58183287 |
| 74 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.57225113 |
| 75 | positive regulation of membrane potential (GO:0045838) | 3.53538605 |
| 76 | respiratory burst (GO:0045730) | 3.50328891 |
| 77 | cellular extravasation (GO:0045123) | 3.49511458 |
| 78 | neuron-neuron synaptic transmission (GO:0007270) | 3.49457885 |
| 79 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.46697463 |
| 80 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.46373225 |
| 81 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.45443302 |
| 82 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.45362826 |
| 83 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.44390931 |
| 84 | prepulse inhibition (GO:0060134) | 3.44219603 |
| 85 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.44155634 |
| 86 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.44146396 |
| 87 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.43720717 |
| 88 | negative regulation of interleukin-12 production (GO:0032695) | 3.43273919 |
| 89 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.42440947 |
| 90 | alanine transport (GO:0032328) | 3.42290385 |
| 91 | response to interleukin-15 (GO:0070672) | 3.42176243 |
| 92 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.41457617 |
| 93 | immunoglobulin mediated immune response (GO:0016064) | 3.40143090 |
| 94 | cerebellar Purkinje cell layer development (GO:0021680) | 3.39520081 |
| 95 | detection of biotic stimulus (GO:0009595) | 3.39269973 |
| 96 | transmission of nerve impulse (GO:0019226) | 3.38232143 |
| 97 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.34057181 |
| 98 | regulation of postsynaptic membrane potential (GO:0060078) | 3.33246180 |
| 99 | mating behavior (GO:0007617) | 3.32688937 |
| 100 | granulocyte activation (GO:0036230) | 3.32430901 |
| 101 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.30429240 |
| 102 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.29913707 |
| 103 | axonal fasciculation (GO:0007413) | 3.29330873 |
| 104 | regulation of synaptic plasticity (GO:0048167) | 3.28867107 |
| 105 | glycine transport (GO:0015816) | 3.28850259 |
| 106 | regulation of regulated secretory pathway (GO:1903305) | 3.27242810 |
| 107 | response to auditory stimulus (GO:0010996) | 3.26554507 |
| 108 | negative regulation of phagocytosis (GO:0050765) | 3.26334578 |
| 109 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.26186657 |
| 110 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.25321461 |
| 111 | positive regulation of synapse maturation (GO:0090129) | 3.24680913 |
| 112 | cell communication by electrical coupling (GO:0010644) | 3.24314951 |
| 113 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.24291685 |
| 114 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.22410189 |
| 115 | response to muramyl dipeptide (GO:0032495) | 3.22243950 |
| 116 | regulation of vesicle fusion (GO:0031338) | 3.22062443 |
| 117 | response to histamine (GO:0034776) | 3.21197615 |
| 118 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.20870205 |
| 119 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.20433378 |
| 120 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.20034482 |
| 121 | auditory behavior (GO:0031223) | 3.19330640 |
| 122 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.18774885 |
| 123 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.15559726 |
| 124 | synaptic vesicle endocytosis (GO:0048488) | 3.14242581 |
| 125 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.13440350 |
| 126 | regulation of gamma-delta T cell activation (GO:0046643) | 3.13115340 |
| 127 | germinal center formation (GO:0002467) | 3.11608260 |
| 128 | dendrite morphogenesis (GO:0048813) | 3.11145825 |
| 129 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.11010496 |
| 130 | vesicle transport along microtubule (GO:0047496) | 3.10486997 |
| 131 | neuronal ion channel clustering (GO:0045161) | 3.09364863 |
| 132 | social behavior (GO:0035176) | 3.07802993 |
| 133 | intraspecies interaction between organisms (GO:0051703) | 3.07802993 |
| 134 | postsynaptic membrane organization (GO:0001941) | 3.07359644 |
| 135 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.07288179 |
| 136 | myeloid cell activation involved in immune response (GO:0002275) | 3.07269510 |
| 137 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.07182678 |
| 138 | regulation of ARF protein signal transduction (GO:0032012) | 3.04788524 |
| 139 | regulation of neurotransmitter secretion (GO:0046928) | 3.03952646 |
| 140 | regulation of glutamate secretion (GO:0014048) | 2.98952227 |
| 141 | macrophage activation (GO:0042116) | 2.96712042 |
| 142 | long-term synaptic potentiation (GO:0060291) | 2.96205488 |
| 143 | cellular response to type I interferon (GO:0071357) | 2.94751136 |
| 144 | type I interferon signaling pathway (GO:0060337) | 2.94751136 |
| 145 | positive regulation of dendritic spine development (GO:0060999) | 2.94185230 |
| 146 | negative regulation of type 2 immune response (GO:0002829) | 2.93998652 |
| 147 | response to type I interferon (GO:0034340) | 2.93485039 |
| 148 | L-amino acid import (GO:0043092) | 2.93005506 |
| 149 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.91428168 |
| 150 | positive regulation of B cell differentiation (GO:0045579) | 2.90997646 |
| 151 | neuromuscular process (GO:0050905) | 2.90721419 |
| 152 | negative regulation of microtubule polymerization (GO:0031115) | 2.90215256 |
| 153 | cellular sodium ion homeostasis (GO:0006883) | 2.88769673 |
| 154 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.88637414 |
| 155 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.88125619 |
| 156 | regulation of B cell differentiation (GO:0045577) | 2.87991176 |
| 157 | cellular response to interleukin-15 (GO:0071350) | 2.87524705 |
| 158 | regulation of synaptic transmission (GO:0050804) | 2.86005326 |
| 159 | synapse assembly (GO:0007416) | 2.85650580 |
| 160 | regulation of neurotransmitter transport (GO:0051588) | 2.85036510 |
| 161 | positive regulation of synaptic transmission (GO:0050806) | 2.84825983 |
| 162 | pentose-phosphate shunt (GO:0006098) | 2.84776394 |
| 163 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.83277861 |
| 164 | learning (GO:0007612) | 2.80778863 |
| 165 | membrane hyperpolarization (GO:0060081) | 2.80594635 |
| 166 | organelle transport along microtubule (GO:0072384) | 2.80377700 |
| 167 | neutrophil mediated immunity (GO:0002446) | 2.80341374 |
| 168 | cell migration in hindbrain (GO:0021535) | 2.80174967 |
| 169 | positive regulation of regulated secretory pathway (GO:1903307) | 2.79826007 |
| 170 | membrane depolarization (GO:0051899) | 2.79646036 |
| 171 | potassium ion import (GO:0010107) | 2.79490963 |
| 172 | leukocyte degranulation (GO:0043299) | 2.79220049 |
| 173 | regulation of macrophage cytokine production (GO:0010935) | 2.75766555 |
| 174 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.72472667 |
| 175 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.72333306 |
| 176 | negative regulation of interleukin-6 production (GO:0032715) | 2.71340870 |
| 177 | protein localization to endosome (GO:0036010) | 2.67460915 |
| 178 | microglial cell activation (GO:0001774) | 2.66560269 |
| 179 | B cell receptor signaling pathway (GO:0050853) | 2.66067666 |
| 180 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.65446659 |
| 181 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.62488809 |
| 182 | regulation of necroptotic process (GO:0060544) | 2.60496914 |
| 183 | regulation of superoxide anion generation (GO:0032928) | 2.60197545 |
| 184 | regulation of type 2 immune response (GO:0002828) | 2.59789843 |
| 185 | modulation by virus of host process (GO:0019054) | 2.58175296 |
| 186 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.57262690 |
| 187 | negative regulation of innate immune response (GO:0045824) | 2.56526127 |
| 188 | regulation of mast cell activation (GO:0033003) | 2.55926548 |
| 189 | response to interferon-alpha (GO:0035455) | 2.55548112 |
| 190 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.54916196 |
| 191 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.54561786 |
| 192 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.54561786 |
| 193 | positive regulation of mast cell activation (GO:0033005) | 2.54222544 |
| 194 | B cell mediated immunity (GO:0019724) | 2.53839141 |
| 195 | negative regulation of T cell mediated immunity (GO:0002710) | 2.53649911 |
| 196 | modulation by symbiont of host cellular process (GO:0044068) | 2.52999717 |
| 197 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.51681190 |
| 198 | defense response to protozoan (GO:0042832) | 2.51335099 |
| 199 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.51106439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.89774918 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.25584579 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.15382402 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.14690603 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.06125577 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.97061443 |
| 7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.91979275 |
| 8 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.90957787 |
| 9 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.88737034 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.79684876 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.79684876 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.75049852 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.74785309 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.69759802 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.68891226 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.65813731 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.64700647 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.61542196 |
| 19 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.57729495 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.57077261 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.56265438 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.53205223 |
| 23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.51513177 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.50011227 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.49578860 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.48036592 |
| 27 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.47098151 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.45817598 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.43795986 |
| 30 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42803030 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.41635814 |
| 32 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.33283708 |
| 33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.30007206 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.27615182 |
| 35 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.26242923 |
| 36 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.17547445 |
| 37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.16934153 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16736058 |
| 39 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.16094250 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.12771063 |
| 41 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.09289921 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 2.01978936 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.99203973 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.95620445 |
| 45 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.94560430 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.92621409 |
| 47 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.91052531 |
| 48 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90867710 |
| 49 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.89088543 |
| 50 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87858020 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.87571536 |
| 52 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.86385784 |
| 53 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.86298169 |
| 54 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.82341161 |
| 55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.81647755 |
| 56 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.81054303 |
| 57 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.78754728 |
| 58 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78481037 |
| 59 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.75857272 |
| 60 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.72349474 |
| 61 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.70559494 |
| 62 | MAF_26560356_Chip-Seq_TH2_Human | 1.65293842 |
| 63 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.64953324 |
| 64 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.64020683 |
| 65 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.56738746 |
| 66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.56648503 |
| 67 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.55260765 |
| 68 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.54942401 |
| 69 | KDM2B_26808549_Chip-Seq_K562_Human | 1.54839833 |
| 70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52517734 |
| 71 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.51786546 |
| 72 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.50118392 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.49634241 |
| 74 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.48944505 |
| 75 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.48473146 |
| 76 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.48017132 |
| 77 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.47785886 |
| 78 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.47292125 |
| 79 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46596275 |
| 80 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.45166568 |
| 81 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44295700 |
| 82 | * P68_20966046_ChIP-Seq_HELA_Human | 1.43829536 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.41768576 |
| 84 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.41522162 |
| 85 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.41374856 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34719382 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34640952 |
| 88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34044611 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32117823 |
| 90 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.31359955 |
| 91 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30562901 |
| 92 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.29433860 |
| 93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29418850 |
| 94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.29367022 |
| 95 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29264107 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.27887594 |
| 97 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.27773985 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27624741 |
| 99 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26499553 |
| 100 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.26241171 |
| 101 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25897194 |
| 102 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25488258 |
| 103 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25223546 |
| 104 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24645738 |
| 105 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.24178680 |
| 106 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23756064 |
| 107 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.23621831 |
| 108 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22375626 |
| 109 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.22259437 |
| 110 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.21960929 |
| 111 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.21821838 |
| 112 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.21775042 |
| 113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21330637 |
| 114 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20895714 |
| 115 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.19108884 |
| 116 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18723510 |
| 117 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.18443915 |
| 118 | MYB_26560356_Chip-Seq_TH1_Human | 1.18392353 |
| 119 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.17465715 |
| 120 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.16165401 |
| 121 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15809307 |
| 122 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.15804537 |
| 123 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.15057880 |
| 124 | AR_19668381_ChIP-Seq_PC3_Human | 1.15037248 |
| 125 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13683852 |
| 126 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.13439652 |
| 127 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.13393072 |
| 128 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13051013 |
| 129 | MYB_26560356_Chip-Seq_TH2_Human | 1.13023136 |
| 130 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10710184 |
| 131 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10653947 |
| 132 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.10336647 |
| 133 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09955138 |
| 134 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.09201959 |
| 135 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.08955551 |
| 136 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08939724 |
| 137 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06994716 |
| 138 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.06037873 |
| 139 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.05559975 |
| 140 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.05289418 |
| 141 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04888951 |
| 142 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.03654609 |
| 143 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03074841 |
| 144 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02050811 |
| 145 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01850779 |
| 146 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.01723202 |
| 147 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01568970 |
| 148 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.99994020 |
| 149 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97343162 |
| 150 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.96189381 |
| 151 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95501605 |
| 152 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.94791786 |
| 153 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94270513 |
| 154 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.93932970 |
| 155 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92392420 |
| 156 | AR_25329375_ChIP-Seq_VCAP_Human | 0.91775523 |
| 157 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.91612019 |
| 158 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.91107947 |
| 159 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.90551764 |
| 160 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.90290874 |
| 161 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.89617505 |
| 162 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.89047659 |
| 163 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88813572 |
| 164 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88144468 |
| 165 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87952563 |
| 166 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.86543476 |
| 167 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.85575324 |
| 168 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84372148 |
| 169 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83264070 |
| 170 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.83191683 |
| 171 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.82568440 |
| 172 | P300_19829295_ChIP-Seq_ESCs_Human | 0.80672564 |
| 173 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.80539896 |
| 174 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.79767316 |
| 175 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.79290615 |
| 176 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.79289555 |
| 177 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78885853 |
| 178 | STAT3_23295773_ChIP-Seq_U87_Human | 0.78248820 |
| 179 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.77474902 |
| 180 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.76927722 |
| 181 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.74691454 |
| 182 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.74309918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.60751901 |
| 2 | MP0003880_abnormal_central_pattern | 4.57587590 |
| 3 | MP0003436_decreased_susceptibility_to | 4.53691777 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.27914538 |
| 5 | MP0003724_increased_susceptibility_to | 3.88134299 |
| 6 | MP0009745_abnormal_behavioral_response | 3.44394106 |
| 7 | MP0002064_seizures | 3.41680485 |
| 8 | MP0004270_analgesia | 3.30760889 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.29873262 |
| 10 | MP0005423_abnormal_somatic_nervous | 3.17479407 |
| 11 | MP0009046_muscle_twitch | 3.09195699 |
| 12 | MP0001968_abnormal_touch/_nociception | 3.01147895 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 3.00641248 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.83825386 |
| 15 | MP0009278_abnormal_bone_marrow | 2.81107405 |
| 16 | MP0002419_abnormal_innate_immunity | 2.79777415 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.74460273 |
| 18 | MP0003329_amyloid_beta_deposits | 2.72194745 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.59317105 |
| 20 | MP0008260_abnormal_autophagy | 2.58554531 |
| 21 | MP0001501_abnormal_sleep_pattern | 2.58122932 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.52923443 |
| 23 | MP0005025_abnormal_response_to | 2.47109635 |
| 24 | MP0001486_abnormal_startle_reflex | 2.43237671 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 2.41433549 |
| 26 | MP0002272_abnormal_nervous_system | 2.39407656 |
| 27 | MP0002822_catalepsy | 2.34279014 |
| 28 | MP0002734_abnormal_mechanical_nocicepti | 2.34068379 |
| 29 | MP0005451_abnormal_body_composition | 2.32475952 |
| 30 | MP0004858_abnormal_nervous_system | 2.31713450 |
| 31 | MP0002733_abnormal_thermal_nociception | 2.28212671 |
| 32 | MP0001533_abnormal_skeleton_physiology | 2.26132270 |
| 33 | MP0005000_abnormal_immune_tolerance | 2.23102304 |
| 34 | MP0002736_abnormal_nociception_after | 2.20679705 |
| 35 | MP0005464_abnormal_platelet_physiology | 2.18614701 |
| 36 | MP0000685_abnormal_immune_system | 2.15772650 |
| 37 | MP0002396_abnormal_hematopoietic_system | 2.15514737 |
| 38 | MP0002132_abnormal_respiratory_system | 2.12685920 |
| 39 | MP0002909_abnormal_adrenal_gland | 2.11122891 |
| 40 | MP0001970_abnormal_pain_threshold | 2.07792456 |
| 41 | MP0001790_abnormal_immune_system | 2.02174705 |
| 42 | MP0005387_immune_system_phenotype | 2.02174705 |
| 43 | MP0002420_abnormal_adaptive_immunity | 2.02111185 |
| 44 | MP0001819_abnormal_immune_cell | 2.01087139 |
| 45 | MP0009785_altered_susceptibility_to | 1.98313451 |
| 46 | MP0002723_abnormal_immune_serum | 1.96558543 |
| 47 | MP0003122_maternal_imprinting | 1.93405032 |
| 48 | MP0001800_abnormal_humoral_immune | 1.91402890 |
| 49 | MP0006276_abnormal_autonomic_nervous | 1.91110575 |
| 50 | MP0004947_skin_inflammation | 1.89178260 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.87346066 |
| 52 | MP0002735_abnormal_chemical_nociception | 1.84598590 |
| 53 | MP0008569_lethality_at_weaning | 1.84124465 |
| 54 | MP0008961_abnormal_basal_metabolism | 1.84035654 |
| 55 | MP0002148_abnormal_hypersensitivity_rea | 1.82208962 |
| 56 | MP0002067_abnormal_sensory_capabilities | 1.81662175 |
| 57 | MP0009780_abnormal_chondrocyte_physiolo | 1.79082841 |
| 58 | MP0006082_CNS_inflammation | 1.75839839 |
| 59 | MP0004811_abnormal_neuron_physiology | 1.72004713 |
| 60 | MP0002557_abnormal_social/conspecific_i | 1.71393815 |
| 61 | MP0003566_abnormal_cell_adhesion | 1.70088047 |
| 62 | MP0000858_altered_metastatic_potential | 1.69402611 |
| 63 | MP0003828_pulmonary_edema | 1.66995052 |
| 64 | MP0004924_abnormal_behavior | 1.66807656 |
| 65 | MP0005386_behavior/neurological_phenoty | 1.66807656 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.62797129 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 1.62797129 |
| 68 | MP0010155_abnormal_intestine_physiology | 1.61429844 |
| 69 | MP0000465_gastrointestinal_hemorrhage | 1.61253702 |
| 70 | MP0003866_abnormal_defecation | 1.58670544 |
| 71 | MP0002184_abnormal_innervation | 1.58603797 |
| 72 | MP0002398_abnormal_bone_marrow | 1.58388445 |
| 73 | MP0002405_respiratory_system_inflammati | 1.57859115 |
| 74 | MP0003172_abnormal_lysosome_physiology | 1.56095643 |
| 75 | MP0000604_amyloidosis | 1.52102089 |
| 76 | MP0000716_abnormal_immune_system | 1.51833887 |
| 77 | MP0001529_abnormal_vocalization | 1.51712551 |
| 78 | MP0003763_abnormal_thymus_physiology | 1.50371259 |
| 79 | MP0000778_abnormal_nervous_system | 1.49867470 |
| 80 | MP0000955_abnormal_spinal_cord | 1.49449455 |
| 81 | MP0004142_abnormal_muscle_tone | 1.49273878 |
| 82 | MP0003879_abnormal_hair_cell | 1.47902332 |
| 83 | MP0003633_abnormal_nervous_system | 1.45101326 |
| 84 | MP0005671_abnormal_response_to | 1.44359153 |
| 85 | MP0001502_abnormal_circadian_rhythm | 1.42032990 |
| 86 | MP0002066_abnormal_motor_capabilities/c | 1.41059380 |
| 87 | MP0003283_abnormal_digestive_organ | 1.40952201 |
| 88 | MP0005645_abnormal_hypothalamus_physiol | 1.39447075 |
| 89 | MP0001845_abnormal_inflammatory_respons | 1.37126719 |
| 90 | MP0003075_altered_response_to | 1.34664005 |
| 91 | MP0004885_abnormal_endolymph | 1.33546679 |
| 92 | MP0001905_abnormal_dopamine_level | 1.32898184 |
| 93 | MP0003690_abnormal_glial_cell | 1.32897104 |
| 94 | MP0002998_abnormal_bone_remodeling | 1.32089447 |
| 95 | MP0002722_abnormal_immune_system | 1.31542530 |
| 96 | MP0009333_abnormal_splenocyte_physiolog | 1.30645656 |
| 97 | MP0002429_abnormal_blood_cell | 1.29638978 |
| 98 | MP0002882_abnormal_neuron_morphology | 1.29121392 |
| 99 | MP0005390_skeleton_phenotype | 1.28080902 |
| 100 | MP0008469_abnormal_protein_level | 1.27547456 |
| 101 | MP0005646_abnormal_pituitary_gland | 1.25936917 |
| 102 | MP0001849_ear_inflammation | 1.25206410 |
| 103 | MP0004808_abnormal_hematopoietic_stem | 1.24622596 |
| 104 | MP0005076_abnormal_cell_differentiation | 1.24207361 |
| 105 | MP0009840_abnormal_foam_cell | 1.21062484 |
| 106 | MP0000678_abnormal_parathyroid_gland | 1.20342197 |
| 107 | MP0000703_abnormal_thymus_morphology | 1.18897806 |
| 108 | MP0000490_abnormal_crypts_of | 1.18719558 |
| 109 | MP0001851_eye_inflammation | 1.18663958 |
| 110 | MP0000689_abnormal_spleen_morphology | 1.18507722 |
| 111 | MP0003631_nervous_system_phenotype | 1.15494538 |
| 112 | MP0008874_decreased_physiological_sensi | 1.14887663 |
| 113 | MP0003634_abnormal_glial_cell | 1.11460142 |
| 114 | MP0008872_abnormal_physiological_respon | 1.09511703 |
| 115 | MP0002877_abnormal_melanocyte_morpholog | 1.09301806 |
| 116 | MP0000013_abnormal_adipose_tissue | 1.07952449 |
| 117 | MP0009764_decreased_sensitivity_to | 1.07328474 |
| 118 | MP0002152_abnormal_brain_morphology | 1.06442256 |
| 119 | MP0005535_abnormal_body_temperature | 1.05954911 |
| 120 | MP0001984_abnormal_olfaction | 1.03631972 |
| 121 | MP0003091_abnormal_cell_migration | 1.01131461 |
| 122 | MP0002069_abnormal_eating/drinking_beha | 1.00940947 |
| 123 | MP0005164_abnormal_response_to | 1.00153269 |
| 124 | MP0008004_abnormal_stomach_pH | 0.99547899 |
| 125 | MP0004883_abnormal_blood_vessel | 0.98481455 |
| 126 | MP0000920_abnormal_myelination | 0.98125990 |
| 127 | MP0003303_peritoneal_inflammation | 0.97678366 |
| 128 | MP0004381_abnormal_hair_follicle | 0.94509030 |
| 129 | MP0005023_abnormal_wound_healing | 0.94436415 |
| 130 | MP0002837_dystrophic_cardiac_calcinosis | 0.93801888 |
| 131 | MP0003448_altered_tumor_morphology | 0.93696233 |
| 132 | MP0001873_stomach_inflammation | 0.93579232 |
| 133 | MP0003279_aneurysm | 0.93534564 |
| 134 | MP0001958_emphysema | 0.93510000 |
| 135 | MP0003453_abnormal_keratinocyte_physiol | 0.93202475 |
| 136 | MP0003787_abnormal_imprinting | 0.92996411 |
| 137 | MP0003806_abnormal_nucleotide_metabolis | 0.92301789 |
| 138 | MP0005310_abnormal_salivary_gland | 0.91411099 |
| 139 | MP0002229_neurodegeneration | 0.87566174 |
| 140 | MP0005623_abnormal_meninges_morphology | 0.85725809 |
| 141 | MP0003183_abnormal_peptide_metabolism | 0.85674233 |
| 142 | MP0000751_myopathy | 0.85429111 |
| 143 | MP0000343_altered_response_to | 0.84014662 |
| 144 | MP0002090_abnormal_vision | 0.83962049 |
| 145 | MP0003123_paternal_imprinting | 0.82564856 |
| 146 | MP0002277_abnormal_respiratory_mucosa | 0.80983391 |
| 147 | MP0004264_abnormal_extraembryonic_tissu | 0.80535305 |
| 148 | MP0005167_abnormal_blood-brain_barrier | 0.80311287 |
| 149 | MP0003632_abnormal_nervous_system | 0.79377049 |
| 150 | MP0001663_abnormal_digestive_system | 0.79240388 |
| 151 | MP0001177_atelectasis | 0.79026803 |
| 152 | MP0003795_abnormal_bone_structure | 0.78114564 |
| 153 | MP0005409_darkened_coat_color | 0.77990354 |
| 154 | MP0004510_myositis | 0.74563701 |
| 155 | MP0003045_fibrosis | 0.73477229 |
| 156 | MP0010234_abnormal_vibrissa_follicle | 0.72512449 |
| 157 | MP0001853_heart_inflammation | 0.72425877 |
| 158 | MP0002796_impaired_skin_barrier | 0.72146248 |
| 159 | MP0005083_abnormal_biliary_tract | 0.71592909 |
| 160 | MP0004185_abnormal_adipocyte_glucose | 0.68323179 |
| 161 | MP0005166_decreased_susceptibility_to | 0.66996195 |
| 162 | MP0000681_abnormal_thyroid_gland | 0.66927368 |
| 163 | MP0009931_abnormal_skin_appearance | 0.63841852 |
| 164 | MP0009763_increased_sensitivity_to | 0.63726611 |
| 165 | MP0010386_abnormal_urinary_bladder | 0.63225135 |
| 166 | MP0005621_abnormal_cell_physiology | 0.62983206 |
| 167 | MP0002089_abnormal_postnatal_growth/wei | 0.62139777 |
| 168 | MP0001664_abnormal_digestion | 0.62063108 |
| 169 | MP0004085_abnormal_heartbeat | 0.61915243 |
| 170 | MP0000747_muscle_weakness | 0.60939968 |
| 171 | MP0004742_abnormal_vestibular_system | 0.60549172 |
| 172 | MP0000750_abnormal_muscle_regeneration | 0.59825317 |
| 173 | MP0005448_abnormal_energy_balance | 0.59394860 |
| 174 | MP0000639_abnormal_adrenal_gland | 0.59141553 |
| 175 | MP0005058_abnormal_lysosome_morphology | 0.58982758 |
| 176 | MP0000631_abnormal_neuroendocrine_gland | 0.58845007 |
| 177 | MP0003137_abnormal_impulse_conducting | 0.58839157 |
| 178 | MP0004145_abnormal_muscle_electrophysio | 0.58096264 |
| 179 | MP0001943_abnormal_respiration | 0.57712250 |
| 180 | MP0005551_abnormal_eye_electrophysiolog | 0.53737324 |
| 181 | MP0000569_abnormal_digit_pigmentation | 0.52417771 |
| 182 | MP0001963_abnormal_hearing_physiology | 0.52406495 |
| 183 | MP0002752_abnormal_somatic_nervous | 0.51288705 |
| 184 | MP0003956_abnormal_body_size | 0.51023950 |
| 185 | MP0010769_abnormal_survival | 0.50346542 |
| 186 | MP0001299_abnormal_eye_distance/ | 0.48500996 |
| 187 | MP0010770_preweaning_lethality | 0.47821380 |
| 188 | MP0002082_postnatal_lethality | 0.47821380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.80653131 |
| 2 | Myokymia (HP:0002411) | 6.30342929 |
| 3 | Focal seizures (HP:0007359) | 5.62135582 |
| 4 | Visual hallucinations (HP:0002367) | 5.57325955 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.38675492 |
| 6 | Myositis (HP:0100614) | 4.75604739 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.65295097 |
| 8 | Supranuclear gaze palsy (HP:0000605) | 4.54252760 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.45274734 |
| 10 | Orchitis (HP:0100796) | 4.28263733 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 4.22604315 |
| 12 | Absence seizures (HP:0002121) | 4.13449567 |
| 13 | Atonic seizures (HP:0010819) | 4.11965035 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.02006713 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 3.89942910 |
| 16 | Epileptic encephalopathy (HP:0200134) | 3.84832601 |
| 17 | Dialeptic seizures (HP:0011146) | 3.80878594 |
| 18 | Neurofibrillary tangles (HP:0002185) | 3.76997805 |
| 19 | Papilledema (HP:0001085) | 3.74419537 |
| 20 | Chronic obstructive pulmonary disease (HP:0006510) | 3.67638898 |
| 21 | Obstructive lung disease (HP:0006536) | 3.67638898 |
| 22 | Cellulitis (HP:0100658) | 3.65912944 |
| 23 | Cerebral inclusion bodies (HP:0100314) | 3.65860247 |
| 24 | Mutism (HP:0002300) | 3.65685901 |
| 25 | Progressive cerebellar ataxia (HP:0002073) | 3.64047097 |
| 26 | Abnormal eating behavior (HP:0100738) | 3.61432119 |
| 27 | Action tremor (HP:0002345) | 3.53121927 |
| 28 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.52083366 |
| 29 | Depression (HP:0000716) | 3.48507481 |
| 30 | Febrile seizures (HP:0002373) | 3.47793782 |
| 31 | Increased IgE level (HP:0003212) | 3.47591584 |
| 32 | Ankle clonus (HP:0011448) | 3.47553549 |
| 33 | Retrobulbar optic neuritis (HP:0100654) | 3.35135486 |
| 34 | Optic neuritis (HP:0100653) | 3.35135486 |
| 35 | Stomatitis (HP:0010280) | 3.31880613 |
| 36 | Postural instability (HP:0002172) | 3.30913986 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 3.20555846 |
| 38 | Hemiplegia (HP:0002301) | 3.18132018 |
| 39 | Peritonitis (HP:0002586) | 3.10092432 |
| 40 | Recurrent fungal infections (HP:0002841) | 3.07303145 |
| 41 | Truncal ataxia (HP:0002078) | 3.06495128 |
| 42 | Abnormality of binocular vision (HP:0011514) | 3.05492525 |
| 43 | Diplopia (HP:0000651) | 3.05492525 |
| 44 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.03938988 |
| 45 | Dysdiadochokinesis (HP:0002075) | 3.02715684 |
| 46 | Polyphagia (HP:0002591) | 3.02585221 |
| 47 | Urticaria (HP:0001025) | 3.01557919 |
| 48 | Anxiety (HP:0000739) | 3.00505009 |
| 49 | Meningitis (HP:0001287) | 2.96513005 |
| 50 | Gingivitis (HP:0000230) | 2.95883965 |
| 51 | Gastrointestinal infarctions (HP:0005244) | 2.94882147 |
| 52 | Dysmetria (HP:0001310) | 2.94801615 |
| 53 | Abnormal social behavior (HP:0012433) | 2.94746034 |
| 54 | Impaired social interactions (HP:0000735) | 2.94746034 |
| 55 | Hypochromic microcytic anemia (HP:0004840) | 2.93943601 |
| 56 | Hemiparesis (HP:0001269) | 2.93474283 |
| 57 | Poor eye contact (HP:0000817) | 2.91145935 |
| 58 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.86954077 |
| 59 | Prolonged bleeding time (HP:0003010) | 2.85142312 |
| 60 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.83527534 |
| 61 | Recurrent skin infections (HP:0001581) | 2.82001045 |
| 62 | Status epilepticus (HP:0002133) | 2.80662745 |
| 63 | Spontaneous hematomas (HP:0007420) | 2.77170571 |
| 64 | Progressive inability to walk (HP:0002505) | 2.74433892 |
| 65 | Abnormality of the lower motor neuron (HP:0002366) | 2.73995480 |
| 66 | Urinary urgency (HP:0000012) | 2.73283541 |
| 67 | Hypochromic anemia (HP:0001931) | 2.72961195 |
| 68 | Episodic fever (HP:0001954) | 2.71317458 |
| 69 | Amyloidosis (HP:0011034) | 2.69004783 |
| 70 | Neuronal loss in central nervous system (HP:0002529) | 2.68657999 |
| 71 | Chest pain (HP:0100749) | 2.66232681 |
| 72 | Amblyopia (HP:0000646) | 2.66115413 |
| 73 | Bradykinesia (HP:0002067) | 2.65247511 |
| 74 | Torticollis (HP:0000473) | 2.64981413 |
| 75 | Agitation (HP:0000713) | 2.64341867 |
| 76 | Broad-based gait (HP:0002136) | 2.62074491 |
| 77 | Genetic anticipation (HP:0003743) | 2.60760184 |
| 78 | Spastic gait (HP:0002064) | 2.58694165 |
| 79 | Broad face (HP:0000283) | 2.55812034 |
| 80 | Megalencephaly (HP:0001355) | 2.54660400 |
| 81 | Intention tremor (HP:0002080) | 2.53169553 |
| 82 | Petechiae (HP:0000967) | 2.50662959 |
| 83 | Epistaxis (HP:0000421) | 2.45657426 |
| 84 | Focal dystonia (HP:0004373) | 2.43650536 |
| 85 | Encephalitis (HP:0002383) | 2.43428862 |
| 86 | Amyotrophic lateral sclerosis (HP:0007354) | 2.43130604 |
| 87 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.41090788 |
| 88 | Recurrent cutaneous fungal infections (HP:0011370) | 2.41090788 |
| 89 | Impaired smooth pursuit (HP:0007772) | 2.39636258 |
| 90 | Insomnia (HP:0100785) | 2.38815114 |
| 91 | Rapidly progressive (HP:0003678) | 2.36808101 |
| 92 | Keratoconjunctivitis sicca (HP:0001097) | 2.32474942 |
| 93 | Psychosis (HP:0000709) | 2.32466121 |
| 94 | Stereotypic behavior (HP:0000733) | 2.31683943 |
| 95 | Gastrointestinal inflammation (HP:0004386) | 2.30529205 |
| 96 | Limb dystonia (HP:0002451) | 2.29609043 |
| 97 | Failure to thrive in infancy (HP:0001531) | 2.27076275 |
| 98 | Craniofacial dystonia (HP:0012179) | 2.27063392 |
| 99 | Loss of speech (HP:0002371) | 2.26398053 |
| 100 | Drooling (HP:0002307) | 2.25560363 |
| 101 | Excessive salivation (HP:0003781) | 2.25560363 |
| 102 | Vasculitis (HP:0002633) | 2.25425159 |
| 103 | Polygenic inheritance (HP:0010982) | 2.24402155 |
| 104 | Rigidity (HP:0002063) | 2.24068015 |
| 105 | Generalized myoclonic seizures (HP:0002123) | 2.23399669 |
| 106 | Hepatosplenomegaly (HP:0001433) | 2.22371992 |
| 107 | Scanning speech (HP:0002168) | 2.21753932 |
| 108 | Abnormality of the peritoneum (HP:0002585) | 2.19973721 |
| 109 | Interstitial pulmonary disease (HP:0006530) | 2.19695940 |
| 110 | Gaze-evoked nystagmus (HP:0000640) | 2.19128916 |
| 111 | Arterial thrombosis (HP:0004420) | 2.18960852 |
| 112 | Ankyloglossia (HP:0010296) | 2.18431951 |
| 113 | Gingival bleeding (HP:0000225) | 2.17666673 |
| 114 | Apathy (HP:0000741) | 2.16843409 |
| 115 | Hypoventilation (HP:0002791) | 2.16528018 |
| 116 | Peripheral hypomyelination (HP:0007182) | 2.15066672 |
| 117 | Slow saccadic eye movements (HP:0000514) | 2.14638883 |
| 118 | Abnormality of glycolipid metabolism (HP:0010969) | 2.13774327 |
| 119 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.13774327 |
| 120 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.13774327 |
| 121 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.13453851 |
| 122 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.12423238 |
| 123 | Inflammation of the large intestine (HP:0002037) | 2.10953427 |
| 124 | Dysostosis multiplex (HP:0000943) | 2.09876347 |
| 125 | Annular pancreas (HP:0001734) | 2.09748013 |
| 126 | Neoplasm of the heart (HP:0100544) | 2.09655292 |
| 127 | Pustule (HP:0200039) | 2.09455535 |
| 128 | Global brain atrophy (HP:0002283) | 2.09111970 |
| 129 | Ventricular fibrillation (HP:0001663) | 2.08883066 |
| 130 | Pheochromocytoma (HP:0002666) | 2.08869414 |
| 131 | Insidious onset (HP:0003587) | 2.08630447 |
| 132 | Termporal pattern (HP:0011008) | 2.08630447 |
| 133 | Metaphyseal cupping (HP:0003021) | 2.07758376 |
| 134 | Increased connective tissue (HP:0009025) | 2.04887924 |
| 135 | Abnormal platelet volume (HP:0011876) | 2.04457696 |
| 136 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.04159883 |
| 137 | Osteomyelitis (HP:0002754) | 2.04106730 |
| 138 | Lower limb muscle weakness (HP:0007340) | 2.02565997 |
| 139 | Dysmetric saccades (HP:0000641) | 2.01786173 |
| 140 | Pointed chin (HP:0000307) | 2.01221657 |
| 141 | Keratoconjunctivitis (HP:0001096) | 2.00210841 |
| 142 | Polycythemia (HP:0001901) | 2.00172965 |
| 143 | Increased serum ferritin (HP:0003281) | 1.99053076 |
| 144 | Sepsis (HP:0100806) | 1.98737996 |
| 145 | Hypertensive crisis (HP:0100735) | 1.98551125 |
| 146 | Abnormality of the corticospinal tract (HP:0002492) | 1.98074631 |
| 147 | Clonus (HP:0002169) | 1.97836002 |
| 148 | Recurrent viral infections (HP:0004429) | 1.96351406 |
| 149 | Microcytic anemia (HP:0001935) | 1.94903718 |
| 150 | EEG with generalized epileptiform discharges (HP:0011198) | 1.94824865 |
| 151 | Resting tremor (HP:0002322) | 1.94604085 |
| 152 | Hypergammaglobulinemia (HP:0010702) | 1.94497248 |
| 153 | Diminished motivation (HP:0000745) | 1.94111002 |
| 154 | Dementia (HP:0000726) | 1.93798823 |
| 155 | Epileptiform EEG discharges (HP:0011182) | 1.93793312 |
| 156 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.92511200 |
| 157 | Distal lower limb muscle weakness (HP:0009053) | 1.92213470 |
| 158 | Skin ulcer (HP:0200042) | 1.91720198 |
| 159 | Granulocytopenia (HP:0001913) | 1.91232697 |
| 160 | Anorexia (HP:0002039) | 1.90367828 |
| 161 | Hypercortisolism (HP:0001578) | 1.90101933 |
| 162 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.88569325 |
| 163 | Hypsarrhythmia (HP:0002521) | 1.88132098 |
| 164 | Vertebral compression fractures (HP:0002953) | 1.87614174 |
| 165 | Abnormality of saccadic eye movements (HP:0000570) | 1.87346637 |
| 166 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.87169417 |
| 167 | Impaired vibratory sensation (HP:0002495) | 1.86069438 |
| 168 | Purpura (HP:0000979) | 1.85248662 |
| 169 | Hemorrhage of the eye (HP:0011885) | 1.85206297 |
| 170 | Pulmonary infiltrates (HP:0002113) | 1.84809814 |
| 171 | Protrusio acetabuli (HP:0003179) | 1.84752685 |
| 172 | Premature loss of primary teeth (HP:0006323) | 1.84612872 |
| 173 | Dilatation of the ascending aorta (HP:0005111) | 1.84586207 |
| 174 | Hypertriglyceridemia (HP:0002155) | 1.84464365 |
| 175 | Abnormality of the pericardium (HP:0001697) | 1.84401765 |
| 176 | Increased IgM level (HP:0003496) | 1.83749757 |
| 177 | Delusions (HP:0000746) | 1.83413242 |
| 178 | Increased cerebral lipofuscin (HP:0011813) | 1.82898314 |
| 179 | Hemoptysis (HP:0002105) | 1.82885507 |
| 180 | Achilles tendon contracture (HP:0001771) | 1.82821777 |
| 181 | Glomerulopathy (HP:0100820) | 1.82412027 |
| 182 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82215603 |
| 183 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82215603 |
| 184 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82215603 |
| 185 | Bronchomalacia (HP:0002780) | 1.81803486 |
| 186 | Gait ataxia (HP:0002066) | 1.81480739 |
| 187 | Acne (HP:0001061) | 1.81288394 |
| 188 | Inability to walk (HP:0002540) | 1.80512257 |
| 189 | Bruising susceptibility (HP:0000978) | 1.79978044 |
| 190 | Obstructive sleep apnea (HP:0002870) | 1.79880387 |
| 191 | Postural tremor (HP:0002174) | 1.79211439 |
| 192 | Pulmonary embolism (HP:0002204) | 1.76488215 |
| 193 | Hypermelanotic macule (HP:0001034) | 1.76311936 |
| 194 | Cervical subluxation (HP:0003308) | 1.75580241 |
| 195 | Easy fatigability (HP:0003388) | 1.72506802 |
| 196 | Cerebral aneurysm (HP:0004944) | 1.72133284 |
| 197 | Disproportionate tall stature (HP:0001519) | 1.71746970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.60655333 |
| 2 | ERN1 | 4.25582190 |
| 3 | NTRK3 | 4.15437592 |
| 4 | EPHA4 | 3.50083500 |
| 5 | MAP2K3 | 3.02991142 |
| 6 | MARK1 | 2.97592436 |
| 7 | MAP4K1 | 2.82856619 |
| 8 | MAP3K4 | 2.75524112 |
| 9 | MINK1 | 2.65379355 |
| 10 | IRAK4 | 2.55925884 |
| 11 | SMG1 | 2.49208675 |
| 12 | NTRK2 | 2.47384219 |
| 13 | MAP3K12 | 2.39274194 |
| 14 | KSR2 | 2.37712337 |
| 15 | EPHB1 | 2.34107127 |
| 16 | PAK6 | 2.27269270 |
| 17 | DAPK2 | 2.17987824 |
| 18 | NTRK1 | 2.16475854 |
| 19 | SIK1 | 2.14861728 |
| 20 | RIPK4 | 2.13995319 |
| 21 | MAP3K3 | 2.00596100 |
| 22 | MAP2K4 | 1.99014307 |
| 23 | TESK2 | 1.94732509 |
| 24 | CAMKK1 | 1.84295140 |
| 25 | TYK2 | 1.84091375 |
| 26 | PRKD3 | 1.77469025 |
| 27 | SIK2 | 1.77018464 |
| 28 | MAP2K7 | 1.74786658 |
| 29 | CSK | 1.66823299 |
| 30 | FES | 1.66476809 |
| 31 | ZAP70 | 1.58072509 |
| 32 | CDK5 | 1.55083689 |
| 33 | BLK | 1.55011052 |
| 34 | TAOK2 | 1.54551848 |
| 35 | TNIK | 1.53901977 |
| 36 | MAP3K13 | 1.53435380 |
| 37 | IRAK3 | 1.52922782 |
| 38 | PNCK | 1.50673937 |
| 39 | TBK1 | 1.49609063 |
| 40 | DAPK1 | 1.48486856 |
| 41 | UHMK1 | 1.47438604 |
| 42 | CDK19 | 1.46125216 |
| 43 | PRKD2 | 1.45826315 |
| 44 | JAK3 | 1.41935836 |
| 45 | ARAF | 1.41037836 |
| 46 | KSR1 | 1.40809936 |
| 47 | TYRO3 | 1.40736061 |
| 48 | PTK6 | 1.39585584 |
| 49 | LATS2 | 1.34422749 |
| 50 | GRK5 | 1.33405408 |
| 51 | MAP3K2 | 1.25347602 |
| 52 | BTK | 1.19673308 |
| 53 | HCK | 1.19271286 |
| 54 | STK38 | 1.17372704 |
| 55 | SIK3 | 1.15402129 |
| 56 | TAOK1 | 1.14872309 |
| 57 | PRKCG | 1.11001520 |
| 58 | PRKCH | 1.07882618 |
| 59 | EPHA2 | 1.06001355 |
| 60 | STK11 | 1.00595121 |
| 61 | ALK | 1.00192815 |
| 62 | IRAK2 | 1.00014876 |
| 63 | TESK1 | 0.98176060 |
| 64 | PAK4 | 0.97604285 |
| 65 | CDK15 | 0.96762853 |
| 66 | CDK18 | 0.96124692 |
| 67 | RET | 0.95326843 |
| 68 | LRRK2 | 0.95102229 |
| 69 | TNK2 | 0.93526545 |
| 70 | CDK14 | 0.93289537 |
| 71 | PAK3 | 0.90423590 |
| 72 | MAPK13 | 0.90045975 |
| 73 | CAMK1 | 0.89945756 |
| 74 | PKN2 | 0.89158447 |
| 75 | JAK2 | 0.88674476 |
| 76 | CDK12 | 0.88443405 |
| 77 | CDK11A | 0.87472412 |
| 78 | MAP3K14 | 0.87360073 |
| 79 | SCYL2 | 0.87326538 |
| 80 | PRKG2 | 0.86521111 |
| 81 | CAMK1G | 0.85452630 |
| 82 | TTN | 0.85433662 |
| 83 | CAMKK2 | 0.84813334 |
| 84 | IKBKE | 0.83606042 |
| 85 | CSF1R | 0.83570279 |
| 86 | FGR | 0.82534917 |
| 87 | PHKG1 | 0.82343900 |
| 88 | PHKG2 | 0.82343900 |
| 89 | KIT | 0.80572742 |
| 90 | MARK2 | 0.80536923 |
| 91 | CAMK2A | 0.79688953 |
| 92 | PRPF4B | 0.79688847 |
| 93 | SYK | 0.79591049 |
| 94 | RIPK1 | 0.74924997 |
| 95 | GRK6 | 0.74378297 |
| 96 | CSNK1G2 | 0.74163869 |
| 97 | RAF1 | 0.73920107 |
| 98 | JAK1 | 0.73817276 |
| 99 | TRIB3 | 0.72579480 |
| 100 | HIPK2 | 0.72006710 |
| 101 | PLK2 | 0.71762963 |
| 102 | MAP3K1 | 0.71756495 |
| 103 | LMTK2 | 0.71134110 |
| 104 | NME2 | 0.70786158 |
| 105 | STK10 | 0.70528480 |
| 106 | FGFR4 | 0.68111819 |
| 107 | MAP2K2 | 0.64690897 |
| 108 | LCK | 0.64231356 |
| 109 | MAP3K8 | 0.63866788 |
| 110 | MATK | 0.62461224 |
| 111 | PDPK1 | 0.62420329 |
| 112 | RPS6KC1 | 0.62106784 |
| 113 | RPS6KL1 | 0.62106784 |
| 114 | LYN | 0.61692484 |
| 115 | DYRK1B | 0.59566025 |
| 116 | PDK1 | 0.59351572 |
| 117 | MAP3K11 | 0.59201748 |
| 118 | KDR | 0.58737818 |
| 119 | CAMK2B | 0.58629938 |
| 120 | PTK2B | 0.57820868 |
| 121 | PRKCZ | 0.56331108 |
| 122 | FYN | 0.55941768 |
| 123 | SGK1 | 0.54130313 |
| 124 | IRAK1 | 0.53528451 |
| 125 | FGFR2 | 0.53429552 |
| 126 | ICK | 0.51320310 |
| 127 | MAPKAPK2 | 0.50185691 |
| 128 | YES1 | 0.50027138 |
| 129 | SGK494 | 0.49791135 |
| 130 | SGK223 | 0.49791135 |
| 131 | MAP3K7 | 0.48639280 |
| 132 | WNK3 | 0.47574343 |
| 133 | RPS6KA3 | 0.46904239 |
| 134 | SGK3 | 0.45162587 |
| 135 | RPS6KA6 | 0.44729397 |
| 136 | DAPK3 | 0.43593216 |
| 137 | BMX | 0.43428896 |
| 138 | OXSR1 | 0.43314025 |
| 139 | DYRK1A | 0.41688497 |
| 140 | MOS | 0.40754678 |
| 141 | PTK2 | 0.40695454 |
| 142 | IKBKB | 0.40643547 |
| 143 | ROCK2 | 0.39876463 |
| 144 | TGFBR2 | 0.39278369 |
| 145 | MAPK10 | 0.38773829 |
| 146 | CAMK2G | 0.36522917 |
| 147 | MAP3K6 | 0.35380288 |
| 148 | CDC42BPA | 0.35212518 |
| 149 | MAPK7 | 0.35207240 |
| 150 | CAMK4 | 0.34036970 |
| 151 | MAP3K5 | 0.33931569 |
| 152 | PRKD1 | 0.33624606 |
| 153 | GRK7 | 0.33239284 |
| 154 | PINK1 | 0.33212095 |
| 155 | SRC | 0.31248189 |
| 156 | RPS6KA2 | 0.30910994 |
| 157 | PRKCB | 0.30058360 |
| 158 | WNK1 | 0.29435245 |
| 159 | DMPK | 0.29254480 |
| 160 | MAPK12 | 0.28491483 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.60349920 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.23087164 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.75392685 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.58798579 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.46233671 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.42482700 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.39634076 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.39551794 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.38360118 |
| 10 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.35985755 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.34217200 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 2.33223137 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 2.33188563 |
| 14 | Olfactory transduction_Homo sapiens_hsa04740 | 2.33054158 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.21659469 |
| 16 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.12438666 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.03125342 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 2.00731441 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.99447312 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.88945409 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.84582679 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.83671245 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.82580477 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.76876031 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.76679026 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74095550 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.70983916 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.69649858 |
| 29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.68578043 |
| 30 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.67659150 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.67569419 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.57735783 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.56382581 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.55757845 |
| 35 | Long-term depression_Homo sapiens_hsa04730 | 1.55627941 |
| 36 | Renin secretion_Homo sapiens_hsa04924 | 1.54868869 |
| 37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.53872219 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.48619265 |
| 39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.47523580 |
| 40 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.44613416 |
| 41 | Taste transduction_Homo sapiens_hsa04742 | 1.43708417 |
| 42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41773430 |
| 43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.41458026 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.40595835 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.37509699 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 1.35622942 |
| 47 | Measles_Homo sapiens_hsa05162 | 1.35464064 |
| 48 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.30982714 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 1.30040819 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 1.29956508 |
| 51 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.28903558 |
| 52 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.27690282 |
| 53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.25138165 |
| 54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23367531 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.23228365 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 1.23177228 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.22933809 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22098936 |
| 59 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.21711857 |
| 60 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.20448436 |
| 61 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.20409458 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 1.19195089 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.18752371 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.17635671 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.17023651 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 1.14369267 |
| 67 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.12956218 |
| 68 | Allograft rejection_Homo sapiens_hsa05330 | 1.11715713 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.10694889 |
| 70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.10667704 |
| 71 | Glioma_Homo sapiens_hsa05214 | 1.10198551 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08905044 |
| 73 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.07229977 |
| 74 | Apoptosis_Homo sapiens_hsa04210 | 1.06839925 |
| 75 | Bladder cancer_Homo sapiens_hsa05219 | 1.06282229 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 1.04600310 |
| 77 | Legionellosis_Homo sapiens_hsa05134 | 1.04276012 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03356797 |
| 79 | Viral myocarditis_Homo sapiens_hsa05416 | 1.02133378 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01338019 |
| 81 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.00573181 |
| 82 | Axon guidance_Homo sapiens_hsa04360 | 0.98964646 |
| 83 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.98380146 |
| 84 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.98197118 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97484426 |
| 86 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.97450649 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94454816 |
| 88 | Melanogenesis_Homo sapiens_hsa04916 | 0.94296108 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92533521 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.92327828 |
| 91 | Bile secretion_Homo sapiens_hsa04976 | 0.91866228 |
| 92 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.90283990 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88844774 |
| 94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88729780 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88018674 |
| 96 | Pertussis_Homo sapiens_hsa05133 | 0.85904152 |
| 97 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.84546535 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.83513888 |
| 99 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.82932415 |
| 100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.82925236 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.81741830 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.78774843 |
| 103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76636337 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74640226 |
| 105 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.74555720 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74079507 |
| 107 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.72156043 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72138325 |
| 109 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.71336803 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68384804 |
| 111 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68096365 |
| 112 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66909373 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66032465 |
| 114 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66004848 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65742571 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65403722 |
| 117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64198638 |
| 118 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64153480 |
| 119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63765771 |
| 120 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.62869768 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61704638 |
| 122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61443159 |
| 123 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59294634 |
| 124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59100924 |
| 125 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58845540 |
| 126 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58481253 |
| 127 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57197255 |
| 128 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57053296 |
| 129 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56685289 |
| 130 | Focal adhesion_Homo sapiens_hsa04510 | 0.56527776 |
| 131 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56250130 |
| 132 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55903515 |
| 133 | Insulin resistance_Homo sapiens_hsa04931 | 0.55340896 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.54685317 |
| 135 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.54566631 |
| 136 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53277032 |
| 137 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53005499 |
| 138 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50200979 |
| 139 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49748516 |
| 140 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.49380374 |
| 141 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.48032569 |
| 142 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46570372 |
| 143 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45390030 |
| 144 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45386981 |
| 145 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44125790 |
| 146 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42539541 |
| 147 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41113009 |
| 148 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.41071105 |
| 149 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40788644 |
| 150 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38160279 |
| 151 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37216226 |
| 152 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36448241 |
| 153 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.34811484 |
| 154 | Lysosome_Homo sapiens_hsa04142 | 0.32764427 |
| 155 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32719691 |
| 156 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.30798038 |
| 157 | Platelet activation_Homo sapiens_hsa04611 | 0.30775118 |
| 158 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29995856 |
| 159 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29662454 |
| 160 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.28767341 |
| 161 | Colorectal cancer_Homo sapiens_hsa05210 | 0.28228482 |
| 162 | Alcoholism_Homo sapiens_hsa05034 | 0.25565136 |

